INSURASALES

Tag: health economics

U.S. Prescription Drug Denials by Private Insurers Increase 25% from 2016 to 2023

Analysis shows a 25% increase in U.S. private insurer prescription drug denials from 2016-2023, driven by rising drug costs and claim automation. Insights into industry impact and reform efforts.

$1 Trillion Medicaid and ACA Cuts Threaten New York Health Coverage

Explore how $1 trillion in federal Medicaid and ACA funding cuts will impact New York's health coverage, rural hospitals, and SNAP nutrition support, with significant economic repercussions.

Hospitals Face Financial Challenges Serving Medicare Inpatient Fee-for-Service Cases

Analysis reveals most hospitals lose money on Medicare inpatient fee-for-service cases, with stronger financial performance in for-profit versus not-for-profit and teaching hospitals due to cost and payment structures.

Medicare Expansion for GLP-1 Agonists Balances Clinical Gains and Cost Risks

New analysis projects increased Medicare spending with expanded GLP-1 receptor agonist coverage for obesity, highlighting clinical benefits and financial challenges.